E-LIB Suche - Ergebnisse für: Hull, Joseph T.

1

5.13 Evaluation of the Efficacy of Viloxazine ER in ADHD In..:

Findling, Robert L. ; Newcorn, Jeffrey H. ; Cutler, Andrew J....
Journal of the American Academy of Child & Adolescent Psychiatry. 62 (2023) 10 - p. S262-S263 , 2023

Link: https://doi.org/10.1016/..

2

2.43 Viloxazine Extended-Release Capsules in Children and A..:

Findling, Robert L. ; Waxmonsky, James G. ; Katic, Alain...
Journal of the American Academy of Child & Adolescent Psychiatry. 62 (2023) 10 - p. S194 , 2023

Link: https://doi.org/10.1016/..

3

Response of peer relations and social activities to treatme..:

Faraone, Stephen V. ; Gomeni, Roberto ; Hull, Joseph T....
Brain and Behavior. 13 (2023) 4 - p. , 2023

Link: https://doi.org/10.1002/..

4

Authors' Reply to Singh and Balasundaram: Comment on "A Pha..:

Nasser, Azmi ; Hull, Joseph T. ; Liranso, Tesfaye...
CNS Drugs. 36 (2022) 12 - p. 1333-1335 , 2022

Link: https://doi.org/10.1007/..

5

A Phase III, Randomized, Double-Blind, Placebo-Controlled T..:

Nasser, Azmi ; Hull, Joseph T. ; Chaturvedi, Soumya A....
CNS Drugs. 36 (2022) 8 - p. 897-915 , 2022

Link: https://doi.org/10.1007/..

6

The role of placebo response in the efficacy outcome assess..:

Nasser, Azmi ; Gomeni, Roberto ; Wang, Zhao...
British Journal of Clinical Pharmacology. 88 (2022) 11 - p. 4828-4838 , 2022

Link: https://doi.org/10.1111/..

7

Predicting efficacy of viloxazine extended-release treatmen..:

Faraone, Stephen V. ; Gomeni, Roberto ; Hull, Joseph T....
Psychiatry Research. 318 (2022) - p. 114922 , 2022

Link: https://doi.org/10.1016/..

8

Chronic Circadian Disruption and Sleep Restriction Influenc..:

McHill, Andrew W. ; Hull, Joseph T. ; Klerman, Elizabeth B.
Nutrients. 14 (2022) 9 - p. 1800 , 2022

Link: https://doi.org/10.3390/..

9

Sleep Restriction and Recurrent Circadian Disruption Differ..:

McMullan, Ciaran J. ; McHill, Andrew W. ; Hull, Joseph T....
Frontiers in Physiology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

10

A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazin..:

Nasser, Azmi ; Liranso, Tesfaye ; Adewole, Toyin...
Journal of Clinical Psychopharmacology. 41 (2021) 4 - p. 370-380 , 2021

Link: https://doi.org/10.1097/..

11

Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD ..:

Nasser, Azmi ; Liranso, Tesfaye ; Adewole, Toyin...
Clinical Therapeutics. 43 (2021) 4 - p. 684-700 , 2021

Link: https://doi.org/10.1016/..

12

A post hoc analysis of the effect of viloxazine extended-re..:

Faraone, Stephen V. ; Gomeni, Roberto ; Hull, Joseph T....
European Child & Adolescent Psychiatry. 32 (2021) 3 - p. 491-499 , 2021

Link: https://doi.org/10.1007/..

13

The Effect of Viloxazine Extended-Release Capsules on Funct..:

Nasser, Azmi ; Hull, Joseph T ; Liranso, Tesfaye...
Neuropsychiatric Disease and Treatment. 17 (2021) - p. 1751-1762 , 2021

Link: https://doi.org/10.2147/..

14

Evaluating the likelihood to be helped or harmed after trea..:

Nasser, Azmi ; Kosheleff, Alisa R. ; Hull, Joseph T....
International Journal of Clinical Practice. 75 (2021) 8 - p. , 2021

Link: https://doi.org/10.1111/..

15

Executive Function Outcome of Treatment with Viloxazine Ext..:

Faraone, Stephen V. ; Gomeni, Roberto ; Hull, Joseph T....
Pediatric Drugs. 23 (2021) 6 - p. 583-589 , 2021

Link: https://doi.org/10.1007/..